Maha Baligh Zickri1, Azza Embaby2, Hala Gabr Metwally3. 1. Department of Histology, Faculty of Medicine, Cairo University, Cairo, Egypt. 2. Department of Histology, Faculty of Medicine, Beni-Suef University, Cairo, Egypt. 3. Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt.
Abstract
BACKGROUND AND OBJECTIVES: The myocyte death that follows intestinal ischemia reperfusion (I/R) injury is a major factor contributing to high mortality and morbidity in ischemic heart disease. The purpose of stem cell (SC) therapy for myocardial infarction is to improve clinical outcomes. The present study aimed at investigating the possible therapeutic effect of intravenous human cord blood mesenchymal stem cells (HCBMSCs) on intestinal ischemia reperfusion induced cardiac muscle injury in albino rat. METHODS AND RESULTS: Thirty male albino rats were divided equally into control (Sham-operated) group, I/R group where rats were exposed to superior mesenteric artery ligation for 1 hour followed by 1 hour reperfusion. In SC therapy group, the rats were injected with HCBMSCs into the tail vein. The rats were sacrificed four weeks following therapy. Cardiac muscle sections were exposed to histological, histochemical, immunohistochemical and morphometric studies. In I/R group, multiple fibers exhibited deeply acidophilic sarcoplasm with lost striations and multiple fibroblasts appeared among the muscle fibers. In SC therapy group, few fibers appeared with deeply acidophilic sarcoplasm and lost striations. Mean area of muscle fibers with deeply acidophilic sarcoplasm and mean area% of fibroblasts were significantly decreased compared to I/R group. Prussion blue and CD105 positive cells were found in SC therapy group among the muscle fibers, inside and near blood vessels. CONCLUSIONS: Intestinal I/R induced cardiac muscle degenerative changes. These changes were ameliorated following HCBMSC therapy. A reciprocal relation was recorded between the extent of regeneration and the existence of undifferentiated mesenchymal stem cells.
BACKGROUND AND OBJECTIVES: The myocyte death that follows intestinal ischemia reperfusion (I/R) injury is a major factor contributing to high mortality and morbidity in ischemic heart disease. The purpose of stem cell (SC) therapy for myocardial infarction is to improve clinical outcomes. The present study aimed at investigating the possible therapeutic effect of intravenous human cord blood mesenchymal stem cells (HCBMSCs) on intestinal ischemia reperfusion induced cardiac muscle injury in albino rat. METHODS AND RESULTS: Thirty male albino rats were divided equally into control (Sham-operated) group, I/R group where rats were exposed to superior mesenteric artery ligation for 1 hour followed by 1 hour reperfusion. In SC therapy group, the rats were injected with HCBMSCs into the tail vein. The rats were sacrificed four weeks following therapy. Cardiac muscle sections were exposed to histological, histochemical, immunohistochemical and morphometric studies. In I/R group, multiple fibers exhibited deeply acidophilic sarcoplasm with lost striations and multiple fibroblasts appeared among the muscle fibers. In SC therapy group, few fibers appeared with deeply acidophilic sarcoplasm and lost striations. Mean area of muscle fibers with deeply acidophilic sarcoplasm and mean area% of fibroblasts were significantly decreased compared to I/R group. Prussion blue and CD105 positive cells were found in SC therapy group among the muscle fibers, inside and near blood vessels. CONCLUSIONS: Intestinal I/R induced cardiac muscle degenerative changes. These changes were ameliorated following HCBMSC therapy. A reciprocal relation was recorded between the extent of regeneration and the existence of undifferentiated mesenchymal stem cells.
Authors: Anita D Szady; Carl J Pepine; Shreela V Sharma; Christopher R Cogle; Emerson C Perin; Stephen G Ellis; Lemuel A Moyé Journal: Curr Atheroscler Rep Date: 2013-08 Impact factor: 5.113
Authors: Thomas J Povsic; Candice Junge; Adel Nada; Richard A Schatz; Robert A Harrington; Charles J Davidson; F David Fortuin; Dean J Kereiakes; Farrell O Mendelsohn; Warren Sherman; Gary L Schaer; Christopher J White; Duncan Stewart; Kenneth Story; Douglas W Losordo; Timothy D Henry Journal: Am Heart J Date: 2013-04-19 Impact factor: 4.749
Authors: Jill J Weyers; Stephen M Schwartz; Elina Minami; Dara D Carlson; Sarah K Dupras; Kevin Weitz; Michael Simons; Timothy C Cox; Charles E Murry; William M Mahoney Journal: J Am Heart Assoc Date: 2013-05-30 Impact factor: 5.501
Authors: Qian Fan; Mai Chen; Lin Zuo; Xiying Shang; Maggie Z Huang; Michele Ciccarelli; Philip Raake; Henriette Brinks; Kurt J Chuprun; Gerald W Dorn; Walter J Koch; Erhe Gao Journal: PLoS One Date: 2013-06-21 Impact factor: 3.240
Authors: Yuanbo Feng; Feng Chen; Yi Xie; Huaijun Wang; Marlein Miranda Cona; Jie Yu; Junjie Li; Jan Bogaert; Stefan Janssens; Raymond Oyen; Yicheng Ni Journal: BMC Med Imaging Date: 2013-07-01 Impact factor: 1.930